All news articles for December 2022

pic:getty/remotevtx

ExPLoRNA Therapeutics receives funding to advance mRNA tech

By Rachel Arthur

ExPLoRNA Therapeutics, a Polish biotech developing mRNA vaccines and therapeutics with improved translational efficiency, has received funding from the Bill & Melinda Gates Foundation to further develop its mRNA technology.

Pic:getty/stanislawpytel

Emmes launches cell and gene therapy center

By Rachel Arthur

Emmes has announced the creation of a dedicated center for cell and gene therapy research: which will focus on supporting clinical trials for the Clinical Research Organization’s (CRO) clients.

© GettyImages/Frank Brennan

ADDF: Anti-amyloids are a promising starting point

By Jane Byrne

The phase 3 trial results for lecanemab and gantenerumab presented at the Clinical Trials on Alzheimer’s Disease (CTAD) conference demonstrate why optimal treatment of Alzheimer’s will require drugs that do more than clear amyloid plaques, says the Alzheimer’s...